Insulet | PODD - Ebitda



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 9.96B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


Ebitda 更改 日
Abbott USD 2.43B 844M 2026-03
Align Technology USD 229.14M 31.74M 2026-03
AtriCure USD 27.28M 10.21M 2026-06
Baxter International USD 309M 756M 2026-03
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Boston Scientific USD 1.63B 27M 2026-06
Cardinal Health USD 1.09B 109M 2026-03
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Globus Medical USD 279.84M 48.01M 2026-06
ICU Medical USD 110.03M 11.35M 2026-06
Insulet USD 199.8M 18.1M 2026-06
Integra LifeSciences USD 78.41M 2.23M 2026-06
J&J USD 8.27B 1.08B 2026-03
Medtronic USD 2.81B 119M 2026-03
Merit Medical Systems USD 104.39M 10.97M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Solventum Corp USD 670M 233M 2026-06
Stryker USD 1.93B 357M 2026-06
Tandem Diabetes Care USD 6.42M 3.69M 2026-06
Teleflex USD 75.63M 171.44M 2026-03
West Pharmaceutical Services USD 243.6M 17.4M 2026-06
Zimmer Biomet Holdings USD 830.5M 190.4M 2026-06